{"id":"https://openalex.org/W69760135","doi":null,"title":"Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer.","display_name":"Single-agent paclitaxel and paclitaxel/non-platinum combination therapy in advanced non-small cell lung cancer.","publication_year":1999,"publication_date":"1999-10-01","ids":{"openalex":"https://openalex.org/W69760135","mag":"69760135","pmid":"https://pubmed.ncbi.nlm.nih.gov/10585009"},"language":"en","primary_location":{"id":"pmid:10585009","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10585009","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},"volume":null,"type":"article","indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078629724","display_name":"Mark A. Socinski","orcid":"https://orcid.org/0000-0003-2915-9325","observed_orcids":["https://orcid.org/0000-0003-2915-9325","https://orcid.org/0000-0002-8213-0137"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M A Socinski","raw_affiliation_strings":["Multidisciplinary Thoracic Oncology Programs of University of North Carolina, Chapel Hill 27599, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multidisciplinary Thoracic Oncology Programs of University of North Carolina, Chapel Hill 27599, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090256464","display_name":"Corey Jay Langer","orcid":"https://orcid.org/0000-0002-8483-6811","observed_orcids":["https://orcid.org/0000-0002-8483-6811"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C J Langer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":2.5546,"has_fulltext":false,"cited_by_count":15,"citation_normalized_percentile":{"value":0.88479639,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"26","issue":"5 Suppl 16","first_page":"51","last_page":"61; discussion 71"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","score":0.49779999256134033,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.48730000853538513,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.007400000002235174,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":1.0},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9729999899864197},{"id":"https://openalex.org/keywords/metastatic-lung-cancer","display_name":"metastatic lung cancer","score":0.7480000257492065},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7540000081062317},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9649999737739563},{"id":"https://openalex.org/keywords/gemcitabine","display_name":"gemcitabine","score":0.9869999885559082},{"id":"https://openalex.org/keywords/vinorelbine","display_name":"vinorelbine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":1.0},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.7870000004768372},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.7360000014305115},{"id":"https://openalex.org/keywords/treatment-schedule","display_name":"treatment schedule","score":0.5080000162124634},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.5950000286102295}],"concepts":[{"id":"https://openalex.org/C2780350996","wikidata":"https://www.wikidata.org/wiki/Q420532","display_name":"Vinorelbine","level":4,"score":0.8995075821876526},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8685067892074585},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8334117531776428},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.7870808839797974},{"id":"https://openalex.org/C2780258809","wikidata":"https://www.wikidata.org/wiki/Q414143","display_name":"Gemcitabine","level":3,"score":0.6862955093383789},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.6803930997848511},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6474447250366211},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.5865517854690552},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5738155245780945},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5364457368850708},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.48985597491264343},{"id":"https://openalex.org/C2778707968","wikidata":"https://www.wikidata.org/wiki/Q417555","display_name":"Teniposide","level":4,"score":0.4883701205253601},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47216054797172546},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.44481533765792847},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.4345473051071167},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.41592320799827576}],"mesh":[{"descriptor_ui":"D000077235","descriptor_name":"Vinorelbine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000093542","descriptor_name":"Gemcitabine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003841","descriptor_name":"Deoxycytidine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:10585009","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10585009","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Seminars in oncology","raw_type":"Journal Article"},{"id":"mag:69760135","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10585009","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2196522623","https://openalex.org/W2310293722","https://openalex.org/W2120272649","https://openalex.org/W2066598037","https://openalex.org/W2441374076","https://openalex.org/W2408773304","https://openalex.org/W2121520519","https://openalex.org/W2400882561","https://openalex.org/W2120540981","https://openalex.org/W2462775402"],"abstract_inverted_index":{"Cumulative":[0],"experience":[1],"with":[2,50,83,90,110,123,144,154,159,244],"single-agent":[3],"paclitaxel":[4,78,103,153,201],"in":[5,48,68,73,136],"advanced":[6],"metastatic":[7],"non-small":[8],"cell":[9,139],"lung":[10,140],"cancer":[11,141],"(NSCLC)":[12],"suggests":[13],"that":[14],"it":[15],"is":[16,33],"a":[17,26,105,145],"highly":[18],"active":[19],"cytotoxic":[20],"agent.":[21],"The":[22,35,166,176,207],"consistent":[23],"finding":[24],"of":[25,58,61,94,108,116,148,162,170,210],"35%":[27],"to":[28,129,227],"40%":[29],"1-year":[30],"survival":[31,215],"rate":[32,107,147,209],"notable.":[34],"major":[36],"toxicities":[37],"include":[38],"neutropenia,":[39],"neuropathy,":[40],"and":[41,63,77,142,164,199,219,238,242],"myalgia/arthralgia":[42],"syndrome.":[43],"Paclitaxel":[44],"has":[45,133,173],"been":[46,174],"used":[47],"combination":[49,169],"several":[51],"other":[52],"nonplatinum":[53,168],"agents":[54],"for":[55,98,180,190,200,231,239],"the":[56],"treatment":[57],"NSCLC.":[59],"Order":[60],"administration":[62],"schedule":[64,89],"are":[65],"clearly":[66],"relevant":[67],"these":[69],"combinations.":[70],"For":[71],"example,":[72],"one":[74],"study,":[75],"etoposide":[76],"given":[79,96],"simultaneously":[80],"proved":[81],"ineffective,":[82],"substantial":[84],"grade":[85],"IV":[86],"neutropenia":[87,113],"Another":[88],"an":[91],"identical":[92],"dose":[93,158,179],"etoposide,":[95],"daily":[97],"3":[99],"days,":[100],"followed":[101],"by":[102],"achieved":[104],"response":[106,124,146,160,208],"41%,":[109],"markedly":[111],"diminished":[112],"A":[114],"variety":[115],"phase":[117],"I":[118],"studies":[119],"have":[120,151],"evaluated":[121],"gemcitabine/paclitaxel,":[122],"rates":[125,161],"ranging":[126],"from":[127],"22%":[128],"30%.":[130],"Paclitaxel/vinorelbine":[131],"also":[132,172],"proven":[134],"feasible":[135],"both":[137],"small":[138],"NSCLC,":[143],"17%.":[149],"Investigators":[150],"combined":[152],"ifosfamide":[155,181],"at":[156],"full":[157],"21%":[163],"23%.":[165],"three-drug":[167],"paclitaxel/ifosfamide/vinorelbine":[171],"studied.":[175],"maximum":[177],"tolerated":[178],"was":[182,212,216,221],"1.2":[183],"g/m2":[184],"on":[185,194,204],"days":[186,195],"1":[187,196],"through":[188,197],"3,":[189,198],"vinorelbine":[191],"20":[192],"mg/m2":[193,203],"175":[202],"day":[205],"1.":[206],"16%":[211],"disappointing.":[213],"Median":[214],"6.1":[217],"months":[218],"toxicity":[220],"substantial.":[222],"Paclitaxel/non-platinum":[223],"combinations":[224],"may":[225],"prove":[226],"be":[228],"reasonable":[229],"alternatives":[230],"NSCLC":[232],"patients":[233,241,243],"who":[234],"cannot":[235],"tolerate":[236],"cisplatin":[237],"relapsed":[240],"compromised":[245],"performance":[246],"status.":[247]},"counts_by_year":[{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}